A comparative analysis of cartilage engineered from different perinatal mesenchymal progenitor cells.

Shaun M Kunisaki, Julie R Fuchs, Shaun A Steigman, Dario O Fauza
{"title":"A comparative analysis of cartilage engineered from different perinatal mesenchymal progenitor cells.","authors":"Shaun M Kunisaki, Julie R Fuchs, Shaun A Steigman, Dario O Fauza","doi":"10.1089/ten.2006.0407","DOIUrl":null,"url":null,"abstract":"We sought to compare engineered cartilaginous constructs derived from different perinatal mesenchymal progenitor cell (MPC) sources. Ovine MPCs isolated from amniotic fluid (AF, n = 8), neonatal bone marrow (BM, n = 6), and preterm umbilical cord blood (CB, n = 12) were expanded and comparably seeded onto synthetic scaffolds. Constructs were maintained in chondrogenic media containing transforming growth factor-beta. After 12-15 weeks, specimens were compared with native fetal hyaline and elastic cartilage by gross inspection, histology, immunohistochemistry, and quantitative extracellular matrix (ECM) assays. MPCs from AF proliferated significantly faster ex vivo when compared to MPCs from the other sources. Chondrogenic differentiation was evident in all groups, as shown by toluidine blue staining and expression of aggrecan, cartilage proteoglycan link protein, and collagen type II. Quantitatively, all engineered specimens had significantly lower levels of glycosaminoglycans than native hyaline cartilage. Elastin levels in AF-based constructs (156.0 +/- 120.4 microg/mg) were comparable to that of native elastic cartilage (235.8 +/- 54.2 microg/mg), both of which were significantly higher than in BM- and CB-based specimens. We conclude that the ECM profile of cartilage engineered from perinatal MPCs is highly dependent on cell source. ECM peculiarities should be considered when designing the optimal cartilaginous bioprosthesis for use in perinatal surgical reconstruction.","PeriodicalId":23102,"journal":{"name":"Tissue engineering","volume":"13 11","pages":"2633-44"},"PeriodicalIF":0.0000,"publicationDate":"2007-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1089/ten.2006.0407","citationCount":"78","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tissue engineering","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/ten.2006.0407","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 78

Abstract

We sought to compare engineered cartilaginous constructs derived from different perinatal mesenchymal progenitor cell (MPC) sources. Ovine MPCs isolated from amniotic fluid (AF, n = 8), neonatal bone marrow (BM, n = 6), and preterm umbilical cord blood (CB, n = 12) were expanded and comparably seeded onto synthetic scaffolds. Constructs were maintained in chondrogenic media containing transforming growth factor-beta. After 12-15 weeks, specimens were compared with native fetal hyaline and elastic cartilage by gross inspection, histology, immunohistochemistry, and quantitative extracellular matrix (ECM) assays. MPCs from AF proliferated significantly faster ex vivo when compared to MPCs from the other sources. Chondrogenic differentiation was evident in all groups, as shown by toluidine blue staining and expression of aggrecan, cartilage proteoglycan link protein, and collagen type II. Quantitatively, all engineered specimens had significantly lower levels of glycosaminoglycans than native hyaline cartilage. Elastin levels in AF-based constructs (156.0 +/- 120.4 microg/mg) were comparable to that of native elastic cartilage (235.8 +/- 54.2 microg/mg), both of which were significantly higher than in BM- and CB-based specimens. We conclude that the ECM profile of cartilage engineered from perinatal MPCs is highly dependent on cell source. ECM peculiarities should be considered when designing the optimal cartilaginous bioprosthesis for use in perinatal surgical reconstruction.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
不同围产期间充质祖细胞工程化软骨的比较分析。
我们试图比较来自不同围产期间充质祖细胞(MPC)来源的工程软骨结构。将从羊水(AF, n = 8)、新生儿骨髓(BM, n = 6)和早产儿脐带血(CB, n = 12)中分离的绵羊MPCs扩增并播种到合成支架上。构建体在含有转化生长因子- β的软骨培养基中维持。12-15周后,通过大体检查、组织学、免疫组织化学和细胞外基质(ECM)定量分析,将标本与天然胎透明软骨和弹性软骨进行比较。与其他来源的MPCs相比,AF的MPCs在体外增殖明显更快。通过甲苯胺蓝染色和聚集蛋白、软骨蛋白聚糖连接蛋白和II型胶原蛋白的表达,所有组的软骨分化都很明显。在数量上,所有工程标本的糖胺聚糖水平明显低于天然透明软骨。af构建的弹性蛋白水平(156.0 +/- 120.4 μ g/mg)与天然弹性软骨(235.8 +/- 54.2 μ g/mg)相当,两者均显著高于BM和cb构建的标本。我们得出结论,围产期MPCs工程软骨的ECM特征高度依赖于细胞来源。在设计用于围产期手术重建的最佳软骨生物假体时,应考虑ECM的特性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Tissue engineering
Tissue engineering CELL & TISSUE ENGINEERING-BIOTECHNOLOGY & APPLIED MICROBIOLOGY
自引率
0.00%
发文量
0
期刊最新文献
Cartilage reshaping via in vitro mechanical loading. ECM molecules mediate both Schwann cell proliferation and activation to enhance neurite outgrowth. Development of custom-built bone scaffolds using mesenchymal stem cells and apatite-wollastonite glass-ceramics. Vascularized adipose tissue grafts from human mesenchymal stem cells with bioactive cues and microchannel conduits. A novel time-varying poly lactic-co glycolic acid external sheath for vein grafts designed under physiological loading.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1